What is OneThree Biotech?
OneThree Biotech operates at the intersection of systems biology and machine learning, providing a clinically validated platform that deciphers complex drug-target-disease relationships. By integrating disparate chemical, biological, and clinical datasets, the company enables pharmaceutical partners to generate actionable hypotheses with unprecedented speed. This proprietary technology has been rigorously tested, evidenced by over 20 peer-reviewed publications and successful outcomes in early-stage development pipelines. The firm's market position is defined by its ability to reduce the inherent risks of drug development, offering a sophisticated computational alternative to traditional, trial-and-error laboratory methods.
How much funding has OneThree Biotech raised?
OneThree Biotech has raised a total of $2.5M across 1 funding round:
Angel/Seed
$2.5M
Angel/Seed (2020): $2.5M with participation from Primary Venture Partners and Meridian Street Capital
Key Investors in OneThree Biotech
Primary Venture Partners
A venture capital firm focused on supporting early-stage companies with high growth potential through strategic mentorship and capital allocation.
Meridian Street Capital
A closely held investment fund that partners with entrepreneurs to foster business development and long-term operational growth.
What's next for OneThree Biotech?
With this major strategic investment, OneThree Biotech is positioned to scale its computational infrastructure and expand its portfolio of industry partnerships. The company is expected to focus on deepening its clinical validation efforts, potentially moving into more complex therapeutic areas where its AI platform can provide the most significant competitive advantage. As the firm matures, the focus will likely shift toward long-term commercialization strategies and the integration of its predictive models into global pharmaceutical R&D workflows, solidifying its role as a critical enabler of modern precision medicine.
See full OneThree Biotech company page